New drug targets Hard-to-Treat cancers with genetic weakness
NCT ID NCT07109726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, TER-2013, in people with advanced solid tumors (like breast, ovarian, or lung cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and can shrink tumors. About 205 participants will receive the drug, and researchers will monitor side effects and how well the cancer responds.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carolina BioOncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact Email: •••••@•••••
-
Florida Cancer Specialists - Lake Nona
RECRUITINGOrlando, Florida, 32827, United States
-
Froedtert & MCW Cancer Center
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02144, United States
-
Mayo Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact Email: •••••@•••••
-
NEXT Oncology
RECRUITINGAustin, Texas, 78229, United States
-
NEXT Oncology
RECRUITINGFairfax, Virginia, 22031, United States
-
Nebraska Cancer Specialists
RECRUITINGOmaha, Nebraska, 68130, United States
-
PanOncology Trials
RECRUITINGSan Juan, 00935, Puerto Rico
Contact Email: •••••@•••••
-
START Center for Cancer Research
RECRUITINGSan Antonio, Texas, 78229, United States
-
START Center for Cancer Research
RECRUITINGWest Valley City, Utah, 84119, United States
-
Sarah Cannon Nashville
RECRUITINGNashville, Tennessee, 37203, United States
-
UH Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
Washington Univ. School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Digital peer support: a new weapon against cancer treatment anxiety?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Can your own immune cells beat advanced cancer?